Sujit Sheth   Professor of Clinical Pediatrics

Dr. Sujit Sheth is the Director of the Division of Pediatric Hematology/Oncology at Weill Cornell Medical College and an Associate Attending Pediatrician at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. He is board-certified in pediatrics and pediatric hematology/oncology, and is an expert in iron metabolism, thalassemia, and sickle cell disease.

Dr. Sheth completed his medical training at the University of Bombay, receiving his medical degree (MBBS) in 1988 and completing his resident specialty training in Pediatrics (MD) in 1991. A year later, he entered Columbia University, College of Physicians & Surgeons as a Post-Doctoral Fellow in Pediatric Hematology/Oncology, completing his fellowship in 1995 and his obligatory additional year of residency in Pediatrics in 1996. Following his residency, Dr. Sheth joined the Columbia University faculty where he was named Assistant Professor of Pediatrics. He assumed responsibility as Clinical Director of the Pediatric Hematology program, and was promoted to Associate Clinical Professor of Pediatrics in 2004.

In addition to his clinical work, Dr. Sheth is recognized for his dedication to medical education. At NewYork-Presbyterian Morgan Stanley Children's Hospital, he was voted Attending of the Year by the Pediatric Housestaff in 2010 and nominated for Teacher of the Year eight times, receiving the honor in 1999. He has served on resident selection and education committees, as well as on the Scientific Advisory Board, Irving Center for Clinical Research at NewYork-Presbyterian Hospital.

Dr. Sheth has also established himself as a physician-scientist with a focus on clinical research related to disorders of iron overload. He has completed work as Principle Investigator on one NIH grant, "Mentored Patient-Oriented Hematology Research Training," and as co-investigator on several other NIH funded studies, and is currently co-investigator on three ongoing NIH studies investigating various aspects of iron metabolism.

Publications

Sort by

selected publications

Research

Sort by

Funding awarded

  • The New York Comprehensive Thalassemia Center - Expanded Network  awarded by Centers for Disease Control & Prevention Principal Investigator 2019 - 2024
  • missing activity Principal Investigator 2019 - 2024
  • missing activity Co-Investigator 2021 - 2024
  • missing activity Co-Investigator 2021 - 2024
  • QSM to Guide Iron Chelating Therapy in Transfusional Iron Overload  awarded by National Institute of Diabetes & Digestive & Kidney Diseases Co-Investigator 2019 - 2024
  • QSM to Guide Iron Chelating Therapy in Transfusional Iron Overload - Administrative Supplement  awarded by National Institute of Diabetes & Digestive & Kidney Diseases Key Personnel 2023 - 2025
  • missing activity Key Personnel 2021 - 2023
  • Improving Access to Comprehensive Thalassemia Care - Eastern Region Network  awarded by Eugene Washington PCORI Engagement Award Principal Investigator Subaward 2021 - 2026
  • missing activity Principal Investigator Subaward 2021 - 2023

Background

Contact

full name

  • Sujit Sheth

primary email

  • shethsu@med.cornell.edu

External Relationships

externalRelationships

  • Relationships and collaborations with for-profit and not-for-profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

    Advisory/Scientific Board Member refers to a group of individuals who have been selected to advise a business regarding any number of issues (e.g., scientific advisory board member, medical advisory board member)Advisory/Scientific Board Member:
    Agios Pharmaceuticals, Inc.; Vertex Pharmaceuticals, Inc.
    Consultant refers to an individual who provides expert advice to a business or entity (e.g., consulting on medical devices or pharmaceuticals)Consultant:
    Bristol-Myers Squibb Company